BWXT stock forecast, quote, news & analysis

Key Takeaways

• BWXT shares traded near $130.88 in late October 2026, down roughly 5.5% from about $138.47 a month earlier, keeping the 30-day move below the 10% threshold.
• The pullback contrasts with a strengthening fundamental picture: second-quarter 2026 revenue rose 18% year over year to $901.6 million, with adjusted earnings of $1.07 per share.
• Management raised its full-year 2026 outlook to about $3.80 billion in revenue, $4.70–$4.80 in adjusted EPS, and $662–$672 million in adjusted EBITDA.
• BWXT ended the second quarter with a roughly $8.4 billion backlog, up about 40% year over year, and a trailing 12-month book-to-bill ratio of 1.7x.
• Commercial Operations revenue surged roughly 72% year over year in the quarter, reflecting nuclear components, field services, fuel handling, and the Kinectrics contribution.
• Get additional detail on the company's Price Targets, Earnings, and Forecast across dedicated pages.
• Explore Trending AI Robots to see how AI-driven trading strategies are tracking BWXT and thousands of other tickers.

Current Market Snapshot

BWX Technologies shares have traded in a choppy, lower range through the fall of 2026. The stock pulled back from the mid-$140s to roughly $130 in a matter of weeks, reflecting profit-taking and broader valuation pressure across the nuclear and defense complex rather than a deterioration in the company's operating results. The recent decline stands in contrast to the multi-year strength of the nuclear theme, where demand tied to naval propulsion, grid decarbonization, and electricity-intensive data centers has kept investor attention elevated.

Sentiment on the name remains mixed. Several analysts reiterated constructive ratings while trimming price targets, and the consensus view still leans positive, though near-term execution and a fourth-quarter-heavy earnings profile have kept a lid on enthusiasm. The stock's move of less than 10% over the trailing 30 days leaves it within a normal trading range for a large-cap industrial.

BWX Technologies (BWXT) Business Overview and Competitive Position

BWX Technologies, Inc. designs and manufactures nuclear components, fuel, and specialized services across two segments: Government Operations and Commercial Operations. In Government Operations, BWXT is the sole manufacturer of nuclear reactors and fuel for the U.S. Navy's submarine and aircraft-carrier fleets, while also handling national security materials, uranium processing, and advanced and microreactor programs. In Commercial Operations, the company supplies steam generators, reactor components, fuel, and field services for commercial nuclear plants, including CANDU reactors, and serves the nuclear medicine market.

The company's competitive moat is built on unique regulatory licenses, security clearances, and highly specialized manufacturing infrastructure that are difficult to replicate. BWXT describes itself as the only large commercial nuclear equipment manufacturer in North America. That positioning, combined with a multi-year backlog concentrated in long-cycle naval propulsion work, gives the company significant revenue visibility and pricing power relative to many industrial peers. Investors follow the stock closely as a bellwether for both U.S. defense spending and the revival of commercial nuclear power.

Recent Developments Driving BWXT

The most consequential recent development was BWXT's decision to raise its 2026 financial guidance following second-quarter results. Revenue of $901.6 million rose 18% year over year, while Commercial Operations revenue climbed roughly 72%, including about 33% organic growth. The company also lifted its full-year free cash flow outlook to $345–$360 million.

Portfolio activity reshaped the business during the period. BWXT completed its acquisition of Precision Components Group in July, adding commercial nuclear manufacturing capability, and agreed to sell just over 80% of its medical business and Kinectrics stable-isotope enrichment operations to Nordic Capital in a transaction valued at up to $800 million, allowing management to focus on nuclear national security and commercial power.

Analyst activity has been mixed. Northland Securities and Jefferies issued Buy ratings in early October, while Truist Financial and Maxim Group maintained Hold ratings, and Wells Fargo reiterated a Hold with a $170 price target. Bank of America trimmed its target from $250 to $210. These revisions, alongside broader sector rotation, contributed to the recent softness in the share price even as the underlying backlog and demand signals remained strong.

Trending AI Robots

Tickeron's Trending AI Robots page highlights a curated selection of AI-driven trading bots. Tickeron offers hundreds of automated bots that monitor thousands of tickers, but only the top-performing and most relevant strategies are surfaced in this section. The bots vary widely in approach, timeframe, and performance metrics, giving traders a way to compare algorithmic strategies rather than relying on a single model. For investors following nuclear and defense names like BWXT, the page offers a window into how quantitative systems are positioning across the market in real time.

2026 Outlook and What Investors Should Watch

BWXT's forward story centers on converting a record backlog into earnings. Management has pointed to the nuclear industry's "multi-decade super cycle," supported by naval propulsion, national security programs, and commercial reactor demand. The company expects its next quarterly earnings release around early November 2026, and consensus estimates point to revenue of roughly $992 million and EPS near $1.19, which will be closely watched for signs that execution remains on track.

Key factors to monitor include the pace of new-build nuclear equipment orders, capacity expansion decisions, and the margin trajectory in Commercial Operations, where management lowered its 2026 adjusted EBITDA margin guidance to about 13% to fund growth investments. The concentration of second-half earnings in the fourth quarter also adds execution risk. On the government side, defense budget priorities and contract award timing remain important swing factors. Broader nuclear peers such as GE Vernova and Huntington Ingalls Industries underscore how demand for nuclear equipment and naval shipbuilding continues to shape the sector's outlook.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations